Moderna Plunges After Big Cut to Sales Forecast
Main points
- The S&P 500 closed 0.2% higher on Monday, January 13, 2025, ahead of the release of inflation data this week and the first wave of earnings reports from the largest U.S. banks.
- Biotechnology company Moderna’s shares tumbled after the company slashed its 2025 revenue guidance, citing uncertainty about vaccine demand.
- Shares of managed care companies rose after the U.S. government proposed increasing Medicare Advantage reimbursement rates next year.
Major U.S. stock indexes mixed new trading week ahead of inflation data This could provide a clearer picture of the interest rate outlook in 2025. The largest U.S. banks are also due to report earnings this week.
The S&P 500 rebounded in the afternoon to close 0.2% higher on Monday after being in the red for most of the day. The Dow rose 0.9%, while the tech-heavy Nasdaq fell 0.4%.
Mosaic Stock (metal oxide semiconductorThe fertilizer maker announced a deal to sell its Patos de Minas phosphate mine in Brazil to a local operator, sending its shares up 8%, the biggest gainer on the S&P 500. A report from Zacks Equity Research last week suggested that Mosaic is poised to benefit from upbeat phosphate and potash fertilizer demand trends, as well as cost-cutting initiatives aimed at combating a challenging fertilizer price environment.
It’s also a positive day for shares of agricultural nutrients maker CF Industries (CF), investment bank Piper Sandler upgraded the stock from “underweight” to “overweight.” CF shares rose 7.6% as analysts forecast lower U.S. grain production and an improving grain price outlook will help support strong pricing in the company’s key nitrogen fertilizer market.
Diagnostics and life sciences company Revvity (RVTY) said its automated test to measure free testosterone levels has received regulatory approval. The company also announced a newborn sequencing research partnership with Element Biosciences. Revvity shares rose 7.8%.
Shares of health care companies involved in managed care plans were higher on Monday after the U.S. government proposed a plan to boost care last week. Medicare Advantages By 2026, reimbursement rates will increase by more than 4%. Shares of CVS Health (CVS) rose 7.3%, while Humana (snort) shares rose 6.8%.
Biotech and pharmaceutical giant Moderna (messenger RNA) Significantly lowers 2025 sales guidance Revenue is expected to increase by $1 billion, with second-half revenue expected to come primarily from COVID-19 and respiratory syncytial virus vaccines. Even though Moderna also announced plans to cut $1 billion this year and another $500 million in 2026, its shares plunged 16.8%, the largest decline in the S&P 500.
As tragic wildfires devastate Southern California, shares of the region’s power company Edison International (axis) continued last week’s sharp decline, falling 11.9% on Monday. Fire agencies are reportedly investigating whether electrical equipment from subsidiary Southern California Edison played a role in igniting the Hurst Fire.
Constellation Energy (CEG) shares fell 8.5%, reversing some of Friday’s moves Increased by more than 25% The news comes after the energy producer announced a deal to acquire rival Calpine. The $26.6 billion deal expands Constellation’s presence in California and Texas, and the company said the merger will create largest clean energy supplier in the united states